(EMAILWIRE.COM, February 18, 2015 ) Dallas, TX — This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration…
http://www.emailwire.com/release/177728-Myotonic-Dystrophy-Therapeutic-Pipeline-Market-Review-H1-2015.html















